Sterile CDMO Focus Position Stira as an end-to-end partner for outsourced sterile injectable development and manufacturing, leveraging in-house platforms and deep expertise across formulation, analytical R&D, stability, microbiology and regulatory support to win programs from biotech and specialty pharma.

Regulatory Acceleration Highlight Regulatory Support as a differentiator to help clients navigate submissions and approvals faster, reducing time-to-market for complex sterile products and peptides.

Testing Excellence Offer integrated testing packages including IVPT, IVRT, E&L, stability and microbiology to shorten development timelines and minimize vendor fragmentation for product development and lifecycle management.

Growth Synergy Emphasize flexible engagement and a mid-sized team that can tailor programs for niche molecules, peptides and small molecules, enabling rapid decision cycles and cost predictability.

Strategic Location Leverage the Fairfield, New Jersey base to approach East Coast biotech clusters, offer proximity-based collaboration, faster tech transfer, and potential logistical and cost advantages for client programs.